seen from Morocco
seen from Algeria
seen from United States
seen from Burkina Faso
seen from T1
seen from United States
seen from United States
seen from United States
seen from Aruba
seen from Jordan
seen from Netherlands
seen from United States
seen from United States
seen from United States
seen from China
seen from Türkiye
seen from Jamaica
seen from United States
seen from China
seen from Iraq
A study by Robert M. Samstein and colleagues revealed that there are divergent effects of BRCA1 and BRCA2 deficiency on Immune Checkpoint Blockade (ICB) outcome and have important implications on the tumour microenvironmental determinants in response to immunotherapy.
If you need immune checkpoint assays for your next research, contact our team at +44 (0)7878279127
